All sponsors

Lepu Biopharma Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS10
PHASE 3 / 2-33
RECRUITING7
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO50%

Delay Index: of 6 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +22.0 months). See all sponsors →

Open Lepu Biopharma Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
MRG003
NCT05126719
P2Active, not recruitingRecurrent or Metastatic Nasopharyngeal Carcinoma2382024-12-30 (+22 mo)
MRG004A plus best supportive care
NCT07138846
P3Not yet recruitingAdvanced Pancreatic Cancer2312027-06
MRG003+HX008
NCT05688605
P1/2RecruitingAdvanced Solid Tumors182027-08 (+27 mo)
MRG003
NCT05751512
P3RecruitingSquamous Cell Carcinoma of the Head and Neck1802027-12 (+28 mo)
MRG006A
NCT07093970
P1/2RecruitingAdvanced Solid Tumors3432027-12
Becotatug Vedotin for Injection
NCT07586124
P2RecruitingHead and Neck Squamous Cell Carcinoma802027-12
Cretostimogene Grenadenorepvec
NCT07283835
P2RecruitingNon Muscle Invasive Bladder Cancer; High-grade Ta/ T1 Papillary Disease Bladder Cancer162027-12-31
MRG006A
NCT07479485
P1/2RecruitingHepatocellular Carcinoma1602028-04
MRG007
NCT07737600
P1/2Not yet recruitingAdvanced Colorectal Cancer3162028-12
Magic-C002
NCT06976190
P3RecruitingRecurrent or Metastatic Nasopharyngeal Carcinoma4462029-05